The store will not work correctly when cookies are disabled.
N'-(4-hydroxy-3-nitrobenzoyl)-3-phenylfuran-2-carbohydrazide
ID: ALA3326178
PubChem CID: 11617576
Max Phase: Preclinical
Molecular Formula: C18H13N3O6
Molecular Weight: 367.32
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NNC(=O)c1occc1-c1ccccc1)c1ccc(O)c([N+](=O)[O-])c1
Standard InChI: InChI=1S/C18H13N3O6/c22-15-7-6-12(10-14(15)21(25)26)17(23)19-20-18(24)16-13(8-9-27-16)11-4-2-1-3-5-11/h1-10,22H,(H,19,23)(H,20,24)
Standard InChI Key: BUDXBKRZWUDJFO-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
8.5348 -2.3474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7885 -2.0145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2412 -2.6213 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6493 -3.3294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4487 -3.1600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0540 -3.7058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8820 -4.5059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4881 -5.0529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2664 -4.8011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4352 -3.9972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8278 -3.4537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3164 -4.0757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5036 -4.1606 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7962 -4.7372 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.1707 -4.9069 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3579 -4.9917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0250 -5.7380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8781 -4.3303 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2118 -5.8180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8789 -6.5634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3589 -7.2259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1756 -7.1380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5048 -6.3923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0270 -7.9726 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0687 -6.6498 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7366 -7.3965 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5870 -5.9931 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 2 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
5 6 1 0
4 12 1 0
12 13 1 0
12 14 2 0
13 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 17 1 0
21 24 1 0
20 25 1 0
25 26 2 0
25 27 1 0
M CHG 2 25 1 27 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 367.32 | Molecular Weight (Monoisotopic): 367.0804 | AlogP: 2.64 | #Rotatable Bonds: 4 |
Polar Surface Area: 134.71 | Molecular Species: ACID | HBA: 6 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 5.75 | CX Basic pKa: ┄ | CX LogP: 2.43 | CX LogD: 0.62 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.48 | Np Likeness Score: -1.12 |
References
1. Hasegawa F, Niidome K, Migihashi C, Murata M, Negoro T, Matsumoto T, Kato K, Fujii A.. (2014) Discovery of furan-2-carbohydrazides as orally active glucagon receptor antagonists., 24 (17): [PMID:25127101] [10.1016/j.bmcl.2014.07.025] |